Courts blocked Apple from enabling blood oxygen sensors in the Apple Watch due to patent infringement on medical device company Masimo, which holds over 1,500 medical technology patents.

Apart from focusing on its consumer business separation, Masimo continues to expand its product portfolio. Earlier this month ...

This was caused by a change in the handling of health data in Wear OS 3.0. Now, a new partnership between Google and Masimo could bring them back into the Wear OS ecosystem. Google and Masimo ...

Masimo (NASDAQ:MASI) partners with Google (GOOG) to develop a new reference platform for original equipment manufacturers ((OEMs)) building Wear OS by Google smartwatches. OEMs who adopt the new ...

Masimo Corp.’s annual shareholder meeting, scheduled for Sept. 19, will determine whether Joe Kiani will remain as chairman of the company he co-founded in 1989. The Irvine maker of non-invasive ...

Joe Kiani remembers the day that everything changed at work. On Feb. 15, 2022, the founder, chairman, and CEO of Masimo announced the $1 billion acquisition of Sound United. While Kiani knew the ...

Masimo Corporation (NASDAQ:MASI) disclosed Friday that it received unsolicited offers from potential acquirers for its ...

Masimo (MASI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Vik Chopra from Wells Fargo maintained a Buy rating on the stock and has ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing ...

Masimo Corporation MASI has announced a partnership with Qualcomm Technologies to create a next-generation smartwatch reference platform for Wear OS by Google. The collaboration is aimed at ...

Masimo has announced collaborations with Google and Qualcomm to build a Wear OS reference platform. This reference platform will feature the Snapdragon W5 Plus Gen 1 processor and Masimo’s ...

Masimo (MASI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Vik Chopra from Wells Fargo maintained a Buy rating on the stock and has a $ ...